This federal contract award, valued at $6,081.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product. This is a firm fixed-price delivery order contract with a period of performance through July 22, 2024.
Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and the Department of Veterans Affairs (VA). The company holds several large Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000, respectively. These contracts enable the government agencies to efficiently procure a wide range of essential medical commodities, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials.
The contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.
Generated 9/27/24, 9:13 AM